FDA Advisers Vote To Include An Omicron-Specific Component For A Coronavirus Booster In The US

FDA Advisers Vote To Include An Omicron-Specific Component For A Coronavirus Booster In The US

The US Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted Tuesday to support recommending inclusion of an Omicron specific component for a Covid-19 booster vaccine.

The post FDA Advisers Vote To Include An Omicron-Specific Component For A Coronavirus Booster In The US appeared first on The Seattle Medium.

hayti ads

Install the app today!

Get in touch with us

Reach out to the Hayti team about
collaborating or working together.

CONTACT info@hayti.com